NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
DIVI'S LABORATORIES LTD. (BSE: 532488)
532488 Technical Analysis
5
As on 24th Dec 2024 532488 SHARE Price closed @ 5783.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3807.54 & Strong Buy for SHORT-TERM with Stoploss of 4254.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
532488SHARE Price
Open | 5842.70 | Change | Price | % |
High | 5910.45 | 1 Day | -64.60 | -1.10 |
Low | 5756.15 | 1 Week | 1156.15 | 24.98 |
Close | 5783.75 | 1 Month | 1156.15 | 24.98 |
Volume | 2165 | 1 Year | 2089.40 | 56.56 |
52 Week High 5910.45 | 52 Week Low 3350.05 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
532488 Daily Charts |
532488 Intraday Charts |
Whats New @ Bazaartrend |
532488 Free Analysis |
|
532488 Important Levels Intraday
RESISTANCE | 6081.09 |
RESISTANCE | 5985.73 |
RESISTANCE | 5926.79 |
RESISTANCE | 5867.84 |
SUPPORT | 5699.66 |
SUPPORT | 5640.71 |
SUPPORT | 5581.77 |
SUPPORT | 5486.41 |
532488 Target May 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
532488 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
532488 Target2025
4th UP Target | 6252.69 |
3rd UP Target | 5498.73 |
2nd UP Target | 5032.69 |
1st UP Target | 4566.65 |
1st DOWN Target | 3236.85 |
2nd DOWN Target | 2770.81 |
3rd DOWN Target | 2304.77 |
4th DOWN Target | 1550.81 |
DIVI'S LABORATORIES LTD. ( BSE INDIA Symbol : 532488 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
532488 Other Details
Segment | EQ | |
Market Capital | 819668582400.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
532488 Address
![]() |
532488 Latest News
532488 Business Profile
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates for in the United States, Asia, Europe, and internationally. The company also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. In addition, it exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service